Thiazide diuretics in advanced chronic kidney disease

Journal of the American Society of Hypertension

Volumn 6, Issue 5, 2012, Pages 299-308

  Agarwal, Rajiv ^a   Sinha, Arjun D ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Chronic kidney disease; diuretics; hypertension; resistant hypertension; thiazides

Indexed keywords

BENDROFLUMETHIAZIDE; BUTIZIDE; CHLORTALIDONE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOOP DIURETIC AGENT; METOLAZONE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE;

ACUTE KIDNEY FAILURE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; DISEASE SEVERITY; DRUG CHOICE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCALCEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERURICEMIA; HYPERVOLEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOVOLEMIA; KIDNEY FAILURE; MEAN ARTERIAL PRESSURE; NEPHROTIC SYNDROME; ORTHOSTATIC HYPOTENSION; PANCREATITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SIDE EFFECT; SODIUM BALANCE; SODIUM EXCRETION; TREATMENT INDICATION; WEIGHT REDUCTION;

ADULT; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOPHYSICAL PROCESSES; BLOOD PRESSURE; BLOOD VOLUME; DISEASE PROGRESSION; DRUG MONITORING; DRUG RESISTANCE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MEDICATION THERAPY MANAGEMENT; MODELS, ANIMAL; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; RENAL INSUFFICIENCY, CHRONIC; SODIUM; SODIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 84866420019     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2012.07.004     Document Type: Review

References (40)

1. J. Coresh, E. Selvin, L.A. Stevens, J. Manzi, J.W. Kusek, and P. Eggers Prevalence of chronic kidney disease in the United States JAMA 298 2007 2038 2247
2. P.A. Sarafidis, S. Li, S.C. Chen, A.J. Collins, W.W. Brown, and M.J. Klag Hypertension awareness, treatment, and control in chronic kidney disease Am J Med 121 2008 332 340 (Pubitemid 351444786)
3. L.C. Plantinga, E.R. Miller 3rd, L.A. Stevens, R. Saran, K. Messer, and N. Flowers Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006 Hypertension 54 2009 47 56
4. P. Muntner, A. Anderson, J. Charleston, Z. Chen, V. Ford, and G. Makos Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study Am J Kidney Dis 55 2009 441 451
5. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtmL/mm6004a4.htm. Accessed June 15, 2012.
6. R. Agarwal, and M.J. Andersen Correlates of systolic hypertension in patients with chronic kidney disease Hypertension 46 2005 514 520 (Pubitemid 41376831)
7. D.C. Crews, L.C. Plantinga, E.R. Miller 3rd, R. Saran, E. Hedgeman, and S.H. Saydah Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States Hypertension 55 2010 1102 1109
8. C.A. Peralta, L.S. Hicks, G.M. Chertow, J.Z. Ayanian, E. Vittinghoff, and F. Lin Control of hypertension in adults with chronic kidney disease in the United States Hypertension 45 2005 1119 1124 (Pubitemid 40770315)
9. T. Kusaba, Y. Mori, O. Masami, N. Hiroko, T. Adachi, and C. Sugishita Sodium restriction improves the gustatory threshold for salty taste in patients with chronic kidney disease Kidney Int 76 2009 638 643
10. M. Heer, F. Baisch, J. Kropp, R. Gerzer, and C. Drummer High dietary sodium chloride consumption may not induce body fluid retention in humans Am J Physiol Renal Physiol 278 2000 F585 F595 (Pubitemid 30215236)
11. A. Machnik, W. Neuhofer, J. Jantsch, A. Dahlmann, T. Tammela, and K. Machura Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism Nat Med 15 2009 545 552
12. C. Kopp, P. Linz, L. Wachsmuth, A. Dahlmann, T. Horbach, and C. Schöfl (23)Na magnetic resonance imaging of tissue sodium Hypertension 59 2012 167 172
13. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252 (Pubitemid 37553153)
14. Available at: http://www.kidney.org/professionals/kdoqi/guidelines-bp/ guide-12.htm. Accessed June 15, 2012.
15. Available at: http://www.cari.org.au/CKD-Prevent-List-Published/Blood- pressure-Control-role-of-specific-antihypertensive.pdf. Accessed June 15, 2012.
16. Available at: http://publications.nice.org.uk/hypertension-cg127/key- priorities-for-implementation#choosing-antihypertensive-drug-treatment. Accessed June 15, 2012.
17. Available at: http://www.hypertension.ca/hypertension-with-compelling- indications-dp1. Accessed June 15, 2012.
18. Available at: http://www.healthquality.va.gov/ckd/ckd-v478-sums.pdf. Accessed June 15, 2012.
19. H.J. Dargie, M.E. Allison, A.C. Kennedy, and M.J. Gray High dosage metolazone in chronic renal failure Br Med J 4 1972 196 198
20. W.M. Bennett, and G.A. Porter Efficacy and safety of metolazone in renal failure and the nephrotic syndrome J Clin Pharmacol 13 1973 357 364
21. P.W. Craswell, E. Ezzat, J. Kopstein, Z. Varghese, and J.F. Moorhead Use of metolazone, a new diuretic, in patients with renal disease Nephron 12 1974 63 73
22. H.J. Dargie, M.E. Allison, A.C. Kennedy, and M.J. Gray Efficacy of metolazone in patients with renal edema Clin Nephrol 2 1974 157 160
23. R.R. Paton, and R.E. Kane Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome J Clin Pharmacol 17 1977 243 251 (Pubitemid 8071319)
24. G.L. Wollam, R.C. Tarazi, E.L. Bravo, and H.P. Dustan Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia Am J Med 72 1982 929 938 (Pubitemid 12086597)
25. W.M. Bennett, W.J. McDonald, E. Kuehnel, M.N. Hartnett, and G.A. Porter Do diuretics have antihypertensive properties independent of natriuresis? Clin Pharmacol Ther 22 1977 499 504 (Pubitemid 8225562)
26. D. Fliser, M. Schroter, M. Nerubeck, and E. Ritz Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure Kidney Int 46 1994 482 488 (Pubitemid 24253057)
27. H. Knauf, and E. Mutschler Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure J Cardiovasc Pharmacol 26 1995 394 400
28. B. Dussol, J. Moussi-Frances, S. Morange, C. Somma-Delpero, O. Mundler, and Y. Berland A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension Nephrol Dial Transplant 20 2005 349 353 (Pubitemid 40276891)
29. B. Dussol, J. Moussi-Frances, S. Morange, C. Somma-Delpero, O. Mundler, and Y. Berland A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease J Clin Hypertens (Greenwich) 14 2012 32 37
30. M.A. Peterzan, R. Hardy, N. Chaturvedi, and A.D. Hughes Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate Hypertension 59 2012 1104 1109
31. M.E. Ernst, B.L. Carter, C.J. Goerdt, J.J. Steffensmeier, B.B. Phillips, and M.B. Zimmerman Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure Hypertension 47 2006 352 358 (Pubitemid 43740274)
32. M.E. Ernst, J.D. Neaton, R.H. Grimm Jr., G. Collins, W. Thomas, and E.Z. Soliman Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial Hypertension 58 2011 1001 1007
33. M.P. Dorsch, B.W. Gillespie, S.R. Erickson, B.E. Bleske, and A.B. Weder Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis Hypertension 57 2011 689 694
34. W.I. Cranston, and B.B. Juel-Jensen The effects of spironolactone and chlorthalidone on arterial pressure Lancet 1962 1161 1164
35. S. Bianchi, R. Bigazzi, and V.M. Campese Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease Kidney Int 70 2006 2116 2123 (Pubitemid 44871374)
36. J.P. Bertocchio, D.G. Warnock, and F. Jaisser Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease Kidney Int 79 2011 1051 1060
37. P. Raheja, A. Price, Z. Wang, D. Arbique, B. Adams-Huet, and R.J. Auchus Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients Hypertension 60 2012 319 325
38. D.N. Juurlink, M.M. Mamdani, D.S. Lee, A. Kopp, P.C. Austin, and A. Laupacis Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551 (Pubitemid 39025171)
39. J. Heshka, M. Ruzicka, S. Hiremath, and B.B. McCormick Spironolactone for difficult to control hypertension in chronic kidney disease: an analysis of safety and efficacy J Am Soc Hypertens 4 2010 295 301
40. R.A. Preston, D. Afshartous, D. Garg, S. Medrano, A.B. Alonso, and R. Rodriguez Mechanisms of impaired potassium handling with dual renin-angiotensin-aldosterone blockade in chronic kidney disease Hypertension 53 2009 754 760